In the multivariate age-adjusted analysis, the study found no association between ovarian cancer and fertility treatments for BRCA1 (OR = 0.81; 95% CI 0.43–1.53) and BRCA2 mutation carriers (OR = 1.01; 95% CI 0.31–3.30). This evidence concerns the gene BRCA2 and ovarian carcinoma.